Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance

Journal of Digestive Diseases

Volumn 11, Issue 5, 2010, Pages 313-318

  Zheng, Qing ^a   Chen, Wan Jun ^a   Lu, Hong ^a   Sun, Qin Juan ^a   Xiao, Shu Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Helicobacter pylori; Primary drug resistance; Quadruple therapy; Triple therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; TETRACYCLINE;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; APPETITE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BITTER TASTE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DYSPEPSIA; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STANDARD; TREATMENT DURATION; VOMITING;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; TETRACYCLINE;

EID: 77957222776     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00457.x     Document Type: Article

References (12)

1. Malfertheiner P, Mégraud F, O'Morain C. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002, 16:167-80.
2. Chui SY, Clay TM, Lyerly HK, Morse MA. The development of therapeutic and preventive vaccines for gastric cancer and Helicobater pylori. Cancer Epidemiol Biomarkers Prev 2005, 14:1883-9.
3. Villoria A, Garcia P, Calvet X, Gisbert JP, Vergara M. Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2008, 28:868-77.
4. Lin YH, Yang XT, Zhang L, Zhang JJ, Wu Q, Wang ZR. Clinical analysis of resistance of Hp isolates of five antibiotics. J Tongji Univ (Med Sci) 2009, 30:86-9. in Chinese
5. Deng WM. Clinical observation of triple therapy for eradication of Helicobacter pylori. Contemp Med 2009, 15:133-4. in Chinese
6. Hu FL, Hu PJ, Liu WZ. The third national consensus report on Helicobacter pylori infection. J Clin Med 2008, 6:13-18. in Chinese
7. Laine L, Hunt R, El-Zimaity H, Nguyen B, Osato M, Spénard J. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. Am J Gastroenterol 2003, 98:562-7.
8. Zheng Q, Dai J, Li XB, Lu H, Xiao SD. Comparison of the efficacy of pantoprazole-based triple therapy versus quadruple therapy in the treatment of Helicobacter pylori infection: a single-center, randomized, open and parallel-controlled Study. Chin J Gastroentero 2009, 14:8-10. in Chinese
9. Mendonça S, Ecclissato C, Sartori MS. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000, 5:79-83.
10. Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004, 20:1071-82.
11. Shi T, Liu WZ, Xiao SD. Change of Helicobacter pylori resistance rate to antibiotics in Shanghai. Chin J Intern Med 2000, 39:576-7. in Chinese
12. Prevalence of Helicobacter pylori resistance to antibiotics and its influence on the treatment outcome in China: a multicenter clinical study. Chin J Gastroenterol 2007, 12:525-30. Chinese Helicobacter pylori Research Group, in Chinese